Wealthcare Advisory Partners’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,100
Closed -$219K 1121
2026
Q1
$219K Sell
4,100
-622
-13% -$36.5K ﹤0.01% 989
2025
Q4
$293K Buy
4,722
+26
+0.6% +$1.6K 0.01% 882
2025
Q3
$282K Sell
4,696
-690
-13% -$42.2K 0.01% 878
2025
Q2
$337K Buy
+5,386
New +$324K 0.01% 752
2021
Q2
Sell
-1,290
Closed -$71K 1172
2021
Q1
$71K Buy
+1,290
New +$71.5K 0.01% 772
2020
Q2
Sell
-654
Closed -$25K 829
2020
Q1
$25K Sell
654
-1,170
-64% -$49.3K ﹤0.01% 674
2019
Q4
$80K Buy
1,824
+354
+24% +$14.9K 0.01% 443
2019
Q3
$61K Buy
+1,470
New +$60.2K 0.01% 490
2019
Q1
Sell
-5,310
Closed -$177K 1245
2018
Q4
$177K Hold
5,310
0.03% 222
2018
Q3
$201K Sell
5,310
-72
-1% -$2.56K 0.04% 223
2018
Q2
$180K Buy
5,382
+72
+1% +$2.35K 0.04% 230
2018
Q1
$164K Hold
5,310
0.04% 217
2017
Q4
$154K Hold
5,310
0.04% 204
2017
Q3
$148K Buy
5,310
+1,638
+45% +$45.3K 0.04% 170
2017
Q2
$102K Hold
3,672
0.05% 38
2017
Q1
$93K Hold
3,672
0.05% 36
2016
Q4
$81K Buy
+3,672
New +$83.4K 0.05% 38

Other funds holding IHI

Wealthcare Advisory Partners's IHI Position: Q2 2026 in Review

Wealthcare Advisory Partners sold out of iShares US Medical Devices ETF (IHI) in Q2 2026, closing a stake of 4,100 shares — an estimated $219K sold.

Wealthcare Advisory Partners first reported a position in IHI in Q4 2016 and held it in 17 quarters. The position peaked at $337K in Q2 2025. 501 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • Wealthcare Advisory Partners reported no remaining iShares US Medical Devices ETF position as of Q2 2026 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 4,100 iShares US Medical Devices ETF shares in Q2 2026, an estimated $219K.
  • Wealthcare Advisory Partners first reported a position in iShares US Medical Devices ETF in Q4 2016 and held it in 17 quarters.
  • Wealthcare Advisory Partners's iShares US Medical Devices ETF position peaked at $337K in Q2 2025.
  • 501 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2026, filed 9 Jul 2026.